Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Enzyme products such as Wobe-Mugos E may help to reduce the side
effects of multiple myeloma therapy. It is not yet known if chemotherapy is more effective
with or without Wobe-Mugos E in treating multiple myeloma.
PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy with or
without Wobe-Mugos E in treating patients who have stage II or stage III multiple myeloma.